vs
Aveanna Healthcare Holdings, Inc.（AVAH）与科睿唯安（CLVT）财务数据对比。点击上方公司名可切换其他公司
Aveanna Healthcare Holdings, Inc.的季度营收约是科睿唯安的1.1倍（$621.9M vs $585.5M），Aveanna Healthcare Holdings, Inc.净利率更高（2.3% vs -6.9%，领先9.1%），Aveanna Healthcare Holdings, Inc.同比增速更快（22.2% vs -1.4%），过去两年Aveanna Healthcare Holdings, Inc.的营收复合增速更高（14.0% vs -5.1%）
Aveanna Healthcare Holdings, Inc.是美国领先的家庭及社区医疗服务提供商，核心业务覆盖儿科家庭护理、成人个人照护、临终关怀、输液治疗等领域，通过覆盖全美的本地护理中心网络为各地患者提供服务，服务对象涵盖公共及私人付费群体。
科睿唯安是一家英美合资的上市分析服务企业，主要提供订阅制信息服务，覆盖文献计量、科学计量、商业与市场情报领域，同时为医药、生物科技行业提供专利、监管合规相关的竞争分析，也提供商标保护、域名与品牌保护服务，旗下Web of Science产品系列还负责计算学术期刊的影响因子。
AVAH vs CLVT — 直观对比
营收规模更大
AVAH
是对方的1.1倍
$585.5M
营收增速更快
AVAH
高出23.6%
-1.4%
净利率更高
AVAH
高出9.1%
-6.9%
两年增速更快
AVAH
近两年复合增速
-5.1%
损益表 — Q3 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $621.9M | $585.5M |
| 净利润 | $14.1M | $-40.2M |
| 毛利率 | 32.6% | 67.2% |
| 营业利润率 | 8.6% | 5.2% |
| 净利率 | 2.3% | -6.9% |
| 营收同比 | 22.2% | -1.4% |
| 净利润同比 | 132.8% | 61.3% |
| 每股收益（稀释后） | $0.06 | $-0.06 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AVAHCLVT
| Q1 26 | — | $585.5M | ||
| Q4 25 | — | $617.0M | ||
| Q3 25 | $621.9M | $623.1M | ||
| Q2 25 | $589.6M | $621.4M | ||
| Q1 25 | $559.2M | $593.7M | ||
| Q4 24 | $519.9M | $663.0M | ||
| Q3 24 | $509.0M | $622.2M | ||
| Q2 24 | $505.0M | $650.3M |
净利润AVAHCLVT
| Q1 26 | — | $-40.2M | ||
| Q4 25 | — | $3.1M | ||
| Q3 25 | $14.1M | $-28.3M | ||
| Q2 25 | $27.0M | $-72.0M | ||
| Q1 25 | $5.2M | $-103.9M | ||
| Q4 24 | $29.2M | $-191.8M | ||
| Q3 24 | $-42.8M | $-65.6M | ||
| Q2 24 | $13.9M | $-304.3M |
毛利率AVAHCLVT
| Q1 26 | — | 67.2% | ||
| Q4 25 | — | 66.8% | ||
| Q3 25 | 32.6% | 65.0% | ||
| Q2 25 | 35.8% | 67.2% | ||
| Q1 25 | 32.8% | 65.1% | ||
| Q4 24 | 33.0% | 65.7% | ||
| Q3 24 | 31.4% | 66.2% | ||
| Q2 24 | 31.3% | 67.2% |
营业利润率AVAHCLVT
| Q1 26 | — | 5.2% | ||
| Q4 25 | — | 6.7% | ||
| Q3 25 | 8.6% | 7.1% | ||
| Q2 25 | 13.6% | 1.1% | ||
| Q1 25 | 9.3% | -3.5% | ||
| Q4 24 | 8.8% | -9.4% | ||
| Q3 24 | 6.7% | 3.5% | ||
| Q2 24 | 7.4% | -36.9% |
净利率AVAHCLVT
| Q1 26 | — | -6.9% | ||
| Q4 25 | — | 0.5% | ||
| Q3 25 | 2.3% | -4.5% | ||
| Q2 25 | 4.6% | -11.6% | ||
| Q1 25 | 0.9% | -17.5% | ||
| Q4 24 | 5.6% | -28.9% | ||
| Q3 24 | -8.4% | -10.5% | ||
| Q2 24 | 2.8% | -46.8% |
每股收益（稀释后）AVAHCLVT
| Q1 26 | — | $-0.06 | ||
| Q4 25 | — | $0.00 | ||
| Q3 25 | $0.06 | $-0.04 | ||
| Q2 25 | $0.13 | $-0.11 | ||
| Q1 25 | $0.03 | $-0.15 | ||
| Q4 24 | $0.15 | $-0.27 | ||
| Q3 24 | $-0.22 | $-0.09 | ||
| Q2 24 | $0.07 | $-0.46 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $145.9M | — |
| 总债务越低越好 | $1.3B | $4.3B |
| 股东权益账面价值 | $9.2M | $4.8B |
| 总资产 | $1.8B | $10.9B |
| 负债/权益比越低杠杆越低 | 141.83× | 0.89× |
8季度趋势，按日历期对齐
现金及短期投资AVAHCLVT
| Q1 26 | — | — | ||
| Q4 25 | — | $329.2M | ||
| Q3 25 | $145.9M | $318.7M | ||
| Q2 25 | $100.7M | $362.6M | ||
| Q1 25 | $71.5M | $354.0M | ||
| Q4 24 | $84.3M | $295.2M | ||
| Q3 24 | $78.5M | $388.5M | ||
| Q2 24 | $47.7M | $376.4M |
总债务AVAHCLVT
| Q1 26 | — | $4.3B | ||
| Q4 25 | — | $4.3B | ||
| Q3 25 | $1.3B | $4.4B | ||
| Q2 25 | $1.3B | $4.5B | ||
| Q1 25 | $1.3B | $4.5B | ||
| Q4 24 | $1.3B | $4.5B | ||
| Q3 24 | $1.3B | $4.6B | ||
| Q2 24 | $1.3B | $4.6B |
股东权益AVAHCLVT
| Q1 26 | — | $4.8B | ||
| Q4 25 | — | $4.8B | ||
| Q3 25 | $9.2M | $4.9B | ||
| Q2 25 | $-12.0M | $5.0B | ||
| Q1 25 | $-100.1M | $5.0B | ||
| Q4 24 | $-123.6M | $5.1B | ||
| Q3 24 | $-156.4M | $5.5B | ||
| Q2 24 | $-119.0M | $5.6B |
总资产AVAHCLVT
| Q1 26 | — | $10.9B | ||
| Q4 25 | — | $11.1B | ||
| Q3 25 | $1.8B | $11.2B | ||
| Q2 25 | $1.8B | $11.4B | ||
| Q1 25 | $1.7B | $11.5B | ||
| Q4 24 | $1.7B | $11.5B | ||
| Q3 24 | $1.6B | $12.0B | ||
| Q2 24 | $1.7B | $12.1B |
负债/权益比AVAHCLVT
| Q1 26 | — | 0.89× | ||
| Q4 25 | — | 0.89× | ||
| Q3 25 | 141.83× | 0.90× | ||
| Q2 25 | — | 0.90× | ||
| Q1 25 | — | 0.90× | ||
| Q4 24 | — | 0.88× | ||
| Q3 24 | — | 0.84× | ||
| Q2 24 | — | 0.83× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $33.2M | $134.7M |
| 自由现金流经营现金流 - 资本支出 | — | $78.9M |
| 自由现金流率自由现金流/营收 | — | 13.5% |
| 资本支出强度资本支出/营收 | — | 9.5% |
| 现金转化率经营现金流/净利润 | 2.36× | — |
| 过去12个月自由现金流最近4个季度 | — | $333.9M |
8季度趋势，按日历期对齐
经营现金流AVAHCLVT
| Q1 26 | — | $134.7M | ||
| Q4 25 | — | $159.9M | ||
| Q3 25 | $33.2M | $181.1M | ||
| Q2 25 | $51.6M | $116.3M | ||
| Q1 25 | $-8.6M | $171.2M | ||
| Q4 24 | $13.4M | $141.3M | ||
| Q3 24 | $29.4M | $202.9M | ||
| Q2 24 | $1.8M | $126.2M |
自由现金流AVAHCLVT
| Q1 26 | — | $78.9M | ||
| Q4 25 | — | $89.2M | ||
| Q3 25 | — | $115.5M | ||
| Q2 25 | — | $50.3M | ||
| Q1 25 | — | $110.3M | ||
| Q4 24 | — | $59.1M | ||
| Q3 24 | — | $126.3M | ||
| Q2 24 | — | $60.3M |
自由现金流率AVAHCLVT
| Q1 26 | — | 13.5% | ||
| Q4 25 | — | 14.5% | ||
| Q3 25 | — | 18.5% | ||
| Q2 25 | — | 8.1% | ||
| Q1 25 | — | 18.6% | ||
| Q4 24 | — | 8.9% | ||
| Q3 24 | — | 20.3% | ||
| Q2 24 | — | 9.3% |
资本支出强度AVAHCLVT
| Q1 26 | — | 9.5% | ||
| Q4 25 | — | 11.5% | ||
| Q3 25 | — | 10.5% | ||
| Q2 25 | — | 10.6% | ||
| Q1 25 | — | 10.3% | ||
| Q4 24 | — | 12.4% | ||
| Q3 24 | — | 12.3% | ||
| Q2 24 | — | 10.1% |
现金转化率AVAHCLVT
| Q1 26 | — | — | ||
| Q4 25 | — | 51.58× | ||
| Q3 25 | 2.36× | — | ||
| Q2 25 | 1.91× | — | ||
| Q1 25 | -1.66× | — | ||
| Q4 24 | 0.46× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.13× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AVAH
| Private Duty Services | $514.4M | 83% |
| Home Health And Hospice | $62.4M | 10% |
| Medical Solutions | $45.1M | 7% |
CLVT
| Subscription | $397.5M | 68% |
| Re-occurring | $108.6M | 19% |
| Transactional | $79.4M | 14% |
